China-Based WuXi Biologics Selects Cranbury, New Jersey for Third U.S. Clinical Manufacturing Campus
06/10/2020
This news follows WuXi Biologics' recent purchase of land to build a new 107,000-square-foot clinical and commercial manufacturing facility in Worcester, Massachusetts, and the lease of a 33,000-square-foot site to establish a process development lab in King of Prussia, Pennsylvania.
According to company officials, the New Jersey clinical manufacturing facility will include 6000 L bioreactors, Process Development, Quality Control labs, along with supporting functions. The 66,000-square-foot facility is expected to become operational in late 2020 and will bring in up to 100 jobs to the region.
"We are excited to announce our third site in the United States and proud to become a member of the New Jersey community. Cranbury is a growing hub for the biotech and biopharma industries and we look forward to working with and serving our partners in the area to benefit patients worldwide," said Dr. Chris Chen, CEO of WuXi Biologics.
WuXi Biologics, a Hong Kong-listed company, noted it is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing.
Project Announcements
Certus Medical Expands Ingham County, Michigan, Operations
04/16/2024
Kalmbach Feeds Expands Wyandot County, Ohio, Operations
04/16/2024
Germany-Based Tesa Tape Relocates-Establishes Grand Rapids, Michigan, Headquarters
04/15/2024
FUJIFILM Diosynth Biotechnologies Expands Holly Springs, North Carolina, Operations
04/15/2024
Two Rivers Lumber Plans Coosa County, Alabama, Sawmill Operations
04/15/2024
Protomet Corporation Plans Rockwood, Tennessee, Operations
04/15/2024
Most Read
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
38th Annual Corporate Survey: Are Unrealized Predictions of an Economic Slump Leading Small to Mid-Size Companies to Put Off Expansion Plans?
Q1 2024
-
Manufacturing Momentum Is Building
Q1 2024
-
20th Annual Consultants Survey: Clients Prioritize Access to Skilled Labor, Responsive State & Local Government
Q1 2024
-
Making Hybrid More Human in 2024
Q1 2024
-
Public-Private Partnerships Incentivize Industrial Development
Q1 2024